• Aptamer-LNPs Enable Targeted PTEN mRNA Delivery in Prostate

  2026-07-14

  This study introduces a DNA aptamer-conjugated lipid nanoparticle (Apt-LNP) system for precise PTEN mRNA delivery to prostate cancer cells. The approach achieves tumor-selective mRNA transfection, robust PTEN restoration, and significant tumor growth inhibition, highlighting a promising advance in gene therapy for castration-resistant prostate cancer.

• Antibacterial Use and Resistance in Psychiatric Hospitals Du

  2026-07-13

  This study provides a retrospective analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the 2022 COVID-19 epidemic. Its findings highlight prudent antibiotic usage yet reveal emerging resistance issues, informing future strategies for antimicrobial stewardship in specialized healthcare settings.

• EdU Flow Cytometry Assay Kits (Cy3): Advanced Cell Cycle Ana

  2026-07-13

  EdU Flow Cytometry Assay Kits (Cy3) from APExBIO deliver high-sensitivity, denaturation-free detection of DNA synthesis, empowering researchers to perform multiplexed cell proliferation and genotoxicity assays. Optimized for compatibility and workflow efficiency, these kits redefine S-phase analysis, particularly in cancer research and drug testing.

• N3-kethoxal for RNA Structure Probing and DNA Accessibility

  2026-07-12

  N3-kethoxal (3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one) empowers precise mapping of RNA secondary structures and accessible DNA regions through selective guanine labeling and click chemistry. Its membrane-permeability and workflow versatility set a new standard for in vitro and in vivo nucleic acid research.

• ML133 HCl: Potent Potassium Channel Inhibitor for PASMC Rese

  2026-07-10

  ML133 HCl stands out as a selective Kir2.1 potassium channel inhibitor, offering precise control in pulmonary artery smooth muscle cell (PASMC) proliferation research. This article delivers actionable workflow enhancements, troubleshooting guidance, and key insights from recent molecular medicine findings to empower robust cardiovascular ion channel studies.

• EdU Flow Cytometry Assay Kits (Cy3): Precision in Cell Cycle

  2026-07-09

  EdU Flow Cytometry Assay Kits (Cy3) empower researchers to quantify DNA synthesis with unmatched sensitivity and workflow flexibility, surpassing traditional BrdU-based approaches. By combining click chemistry with multiplexing compatibility, these kits streamline cell proliferation studies and enable robust genotoxicity and pharmacodynamic assessments.

• LNP-Stabilized Emulsions Enable Targeted mRNA Vaccination

  2026-07-09

  Zhou et al. introduce a lipid nanoparticle-stabilized emulsion (LSE) system that enables precise, spatiotemporal mRNA delivery to antigen-presenting cells. This approach significantly enhances T cell immunity by overcoming limitations of conventional mRNA vaccine platforms, offering new avenues for improved vaccine design and immunotherapy.

• A-769662: Advanced AMPK Activator for Metabolic Studies

  2026-07-08

  A-769662 is transforming metabolic research by providing precise, reversible AMPK activation, allowing direct investigation of energy metabolism and fatty acid synthesis inhibition. Recent paradigm-shifting findings demand new experimental best practices, making this compound an essential tool for dissecting autophagy, proteasome function, and metabolic disease mechanisms.

• nor-NOHA Acetate: Precision Arginase Inhibition in Cancer Re

  2026-07-08

  nor-NOHA acetate delivers reliable, potent, and reversible arginase inhibition—empowering researchers to dissect arginine metabolism and immune escape in cancer models with exceptional specificity. Its protocol versatility and robust performance in both in vitro and in vivo systems make it a leading choice for translational workflows targeting immunometabolic vulnerabilities.

• NADH in Mitochondrial Dysfunction: Advanced Research Insight

  2026-07-07

  Explore how NADH (reduced nicotinamide adenine dinucleotide) drives breakthrough research in mitochondrial dysfunction, energy metabolism, and disease modeling. This article delivers a deeper mechanistic perspective and practical guidance for assay design.

• Coronavirus Macrodomains, PARP Inhibition, and Host Antivira

  2026-07-07

  The reference study reveals that coronavirus macrodomains are essential to counteract PARP-mediated restriction of viral replication and to regulate interferon expression. This work clarifies the interplay between viral evasion mechanisms and host ADP-ribosylation signaling, highlighting the central roles of PARP12 and PARP14 in innate immunity.

• Integrating Vascular Responsiveness Metrics with (-)-Norepin

  2026-07-06

  Uncover how (-)-Norepinephrine (+)-bitartrate advances cardiovascular research through the lens of vascular responsiveness and outcome prediction. This article provides a unique, evidence-based framework for optimizing experimental design and translational insights.

• Cyanine 5-dCTP: Advancing Enzymatic DNA Synthesis Precision

  2026-07-06

  Explore how Cyanine 5-dCTP enhances enzymatic DNA synthesis and fluorescent DNA labeling. This in-depth analysis uncovers unique workflow optimizations rooted in 3D DNA nanostructure innovations, offering practical insights for sensitive nucleic acid detection.

• Lamotrigine’s Dual Modulation: Sodium Channels, 5-HT, and Ar

  2026-07-05

  Explore the unique role of Lamotrigine in neuroscience and endocrine research, highlighting its modulation of sodium channels, serotonin signaling, and human aromatase inhibition. This in-depth analysis goes beyond conventional perspectives to reveal new assay implications.

• Cy5.5 NHS Ester (Non-Sulfonated): Optimizing In Vivo Imaging

  2026-07-04

  Unlock robust near-infrared fluorescence imaging with Cy5.5 NHS ester (non-sulfonated), a high-performance dye for precise protein and polysaccharide labeling. Explore advanced protocol optimizations, troubleshooting insights, and practical strategies inspired by the latest in vivo distribution studies.

16212 records 1/1081 page Next 12345 下5页 Last page